US2004209997A1PendingUtilityA1
Process for cross-linking an acrylic polymer or copolymer or an acrylic derivative of a copolymer and the cross-linked acrylic polymer thereby obtained
Est. expiryDec 27, 2020(expired)· nominal 20-yr term from priority
C08F 220/56
22
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A cross-linked acrylic polymer that is highly biocompatible is prepared from a water-soluble acrylamide monomer by preparing an aqueous polymerization solution containing an acrylamide monomer and a catalyzing agent; polymerizing the monomer present in the polymerization solution by agitating and heating the polymerization solution. The polymerization is conducted in the presence of gaseous oxygen.
Claims
exact text as granted — not AI-modified1 - 12 . (Canceled)
13 . A cross-linked acrylic polymer, comprising:
in polymerized form at least one water-soluble acrylamide monomer; wherein said cross-linked acrylic polymer is in the form of a hydrogel with imide-amide cross links.
14 . The cross-linked acrylic polymer according to claim 13 , wherein said hydrogel with imide-amide cross links is represented by the following formulas
wherein R is an alkylene group.
15 . The cross-linked acrylic polymer according to claim 13 , having a pH between 6.5 and 7.5.
16 . The cross-linked acrylic polymer according to claim 13 , having a dry residue between 3 and 4.
17 . The cross-linked acrylic polymer according to claim 13 , which is insoluble in water.
18 . A cross-linked chelated acrylic polymer, comprising:
in polymerized form at least one water-soluble acrylamide monomer; and a chelating metal cation; wherein said cross-linked chelated acrylic polymer is in the form of a hydrogel with imide-amide cross links.
19 . The cross-linked chelated acrylic polymer according to claim 18 , wherein said hydrogel with imide-amide cross links is represented by the following formulas
wherein R is an alkylene group.
20 . The cross-linked chelated acrylic polymer according to claim 18 , having a pH between 6.5 and 7.5.
21 . The cross-linked chelated acrylic polymer according to claim 18 , having a dry residue between 3 and 4.
22 . The cross-linked chelated acrylic polymer according to claim 18 , which is insoluble in water.
23 . The cross-linked chelated acrylic polymer according to claim 18 , wherein said chelating metal cation is aluminum, zirconium or titanium.
24 . A cross-linked acrylic copolymer, comprising:
in polymerized form at least one water-soluble acrylamide monomer; and a comonomer selected from the group consisting of N,N′-methylene-bis-acrylamide, N,N′-ethylene-bis-acrylamide and methylolacrylamide; wherein said cross-linked acrylic polymer is in the form of a hydrogel with imide-amide cross links.
25 . The cross-linked acrylic polymer according to claim 24 , comprising N,N′-methylene-bis-acrylamide.
26 . The cross-linked acrylic polymer according to claim 24 , comprising N,N′-ethylene-bis-acrylamide.
27 . The cross-linked acrylic polymer according to claim 24 , comprising methylolacrylamide.
28 . The cross-linked acrylic polymer according to claim 24 , wherein said hydrogel with imide-amide cross links is represented by the following formulas
wherein R is an alkylene group.
29 . The cross-linked acrylic polymer according to claim 24 , having a pH between 6.5 and 7.5.
30 . The cross-linked acrylic polymer according to claim 24 , having a dry residue between 3 and 4.
31 . The cross-linked acrylic polymer according to claim 24 , which is insoluble in water.
32 . The cross-linked acrylic polymer according to claim 24 , comprising:
from 2 to 7% of acrylamide; from 0.2 to 4% of N,N′-methylene-bis-acrylamide; and from 0.1 to 4% of N,N′-ethylene-bis-acrylamide.
33 . The cross-linked acrylic polymer according to claim 13 , which is biocompatible.
34 . The cross-linked acrylic polymer according to claim 18 , which is biocompatible.
35 . The cross-linked acrylic polymer according to claim 24 , which is biocompatible.
36 . A method of implanting, comprising:
injecting the cross-linked acrylic polymer according to claim 13 into a subject in need thereof, to obtain a permanent capsule which isolates the cross-linked acrylic polymer from surrounding tissue.
37 . A method of implanting, comprising:
injecting the cross-linked acrylic polymer according to claim 18 into a subject in need thereof, to obtain a permanent capsule which isolates the cross-linked acrylic polymer from surrounding tissue.
38 . A method of implanting, comprising:
injecting the cross-linked acrylic polymer according to claim 24 into a subject in need thereof, to obtain a permanent capsule which isolates the cross-linked acrylic polymer from surrounding tissue.Join the waitlist — get patent alerts
Track US2004209997A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.